Associations between USF1 gene variants and cardiovascular risk factors in the Quebec Family Study

Clinical Genetics

Volumn 71, Issue 3, 2007, Pages 245-253

  Choquette, A C ^a,b,c   Bouchard, L ^a,b,c   Houde, A ^a   Bouchard, C ^d   Perusse L ^a,b   Vohl, Marie Claude ^a,b,c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Cardiovascular risk factor; Metabolic syndrome; Obesity; Upstream transcription factor 1

Indexed keywords

APOLIPOPROTEIN B100; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; TRIACYLGLYCEROL; UPSTREAM STIMULATORY FACTOR 1;

ADULT; AMINO ACID SEQUENCE; ANTHROPOMETRY; ARTICLE; CANADA; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FAMILY STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHESIS; INTRON; MALE; NUCLEOTIDE SEQUENCE; OBESITY; PARTICLE SIZE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; RISK FACTOR; SEQUENCE ANALYSIS; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33847251070     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00755.x     Document Type: Article

References (27)

1. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001: 285 (19): 2486-2497.
2. Shieh BH, Sparkes RS, Gaynor RB, Lusis AJ. Localization of the gene-encoding upstream stimulatory factor (USF) to human chromosome 1q22-q23. Genomics 1993: 16 (1): 266-268.
3. Gregor PD, Sawadogo M, Roeder RG. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev 1990: 4 (10): 1730-1740.
4. Rodriguez CI, Girones N, Fresno M. Cha, a basic helix-loop-helix transcription factor involved in the regulation of upstream stimulatory factor activity. J Biol Chem 2003: 278 (44): 43135-43145.
5. Casado M, Vallet VS, Kahn A, Vaulont S. Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver. J Biol Chem 1999: 274 (4): 2009-2013.
6. Pajukanta P, Lilja HE, Sinsheimer JS et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet 2004: 36 (4): 371-376.
7. Ribeiro A, Pastier D, Kardassis D, Chambaz J, Cardot P. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J Biol Chem 1999: 274 (3): 1216-1225.
8. Shoulders CC. USF1 on trial. Nat Genet 2004: 36 (4): 322-323.
9. Shoulders CC, Naoumova RP. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome. Trends Mol Med 2004: 10 (8): 362-365.
10. Pei W, Baron H, Muller-Myhsok B et al. Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families. Clin Genet 2000: 57 (1): 29-34.
11. Bouchard C. Genetic epidemiology, association, and sib-pair linkage: results from the Québec Family Study. In: Bray GA, Ryan DH, eds. Molecular and genetic aspects of obesity. Baton Rouge, LA: Louisiana State University Press, 1996: 470-481.
12. Bosse Y, Feitosa MF, Despres JP et al. Detection of a major gene effect for LDL peak particle diameter and association with apolipoprotein H gene haplotype. Atherosclerosis 2005: 182 (2): 231-239.
13. The Airlie (VA) Consensus Conference. In: Lohman T, Roche A, Martorel R, eds. Standardization of anthropometric measurements. Human Kinetics Publishers, 1988: 39-80.
14. Bosse Y, Chagnon YC, Despres JP et al. Compendium of genome-wide scans of lipid-related phenotypes: Adding a new genome-wide search of apolipoprotein levels. J Lipid Res. 2004: 45 (12): 2174-2184.
15. St Pierre AC, Ruel IL, Cantin B et al. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 2001: 104 (19): 2295-2299.
16. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990: 82 (2): 495-506.
17. Connelly PW, Poapst M, Davignon J et al. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group. Can J Cardiol 1999: 15 (4): 409-418.
18. Bonfield JK, Smith K, Staden R. A new DNA sequence assembly program. Nucleic Acids Res 1995: 23 (24): 4992-4999.
19. Richterich R, Dauwalder H. [Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method]. Schweiz Med Wochenschr 1971: 101 (17): 615-618.
20. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 1971: 33 (5): 732-738.
21. Botma GJ, Verhoeven AJ, Jansen H. Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor. Atherosclerosis 2001: 154 (3): 625-632.
22. Ayyobi AF, Brunzell JD. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia. Am J Cardiol 2003: 92 (4A): 27J-33J.
23. Putt W, Palmen J, Nicaud V et al. Variation in USF1 shows haplotype effects, Eene: Gene and gene: environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum Mol Genet 2004: 13 (15): 1587-1597.
24. Wang D, Sul HS. Upstream stimulatory factors bind to insulin response sequence of the fatty acid synthase promoter. USF1 is regulated. J Biol Chem 1995: 270 (48): 28716-28722.
25. Wang D, Sul HS. Upstream stimulatory factor binding to the E-box at -65 is required for insulin regulation of the fatty acid synthase promoter. J Biol Chem 1997: 272 (42): 26367-26374.
26. Naukkarinen J, Gentile M, Soro-Paavonen A et al. USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum Mol Genet 2005: 14 (17): 2595-2605.
27. Hoffstedt J, Ryden M, Wahrenberg H, van Harmelen V, Arner P. Upstream transcription factor-1 gene polymorphism is associated with increased adipocyte lipolysis. J Clin Endocrinol Metab 2005: 90 (9): 5356-5360.